Sonoma expands Medline distribution to Canada and OTC retail in US and Canada

Sonoma Pharmaceuticals, Inc.

Amendment No. 1 to Distribution Agreement with Medline dated Oct 17, 2024 adds Canada and OTC wound care sales to retailers.
Original 5-year US distribution deal signed Aug 19, 2024; now covers both countries and OTC channel.
Updated investor presentation (Oct 22, 2024) highlights 20% YoY European revenue growth in Q1 FY2025 and gross margin improvement to 39%.
New FDA 510(k) clearance received Sep 2024 for OTC face/eyelid/eyelash indications and smaller product size.
Distribution expanded in Ukraine, South Korea, and EU through new partners in 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.